BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2850377)

  • 1. [Serum and tissue prolyl hydroxylase (PH) in hepatocellular carcinoma and gastrointestinal cancer].
    Suzuki M; Suzuki H; Kato Y; Okabe K; Uchikoshi T; Okazaki N
    Nihon Shokakibyo Gakkai Zasshi; 1988 Oct; 85(10):2232-8. PubMed ID: 2850377
    [No Abstract]   [Full Text] [Related]  

  • 2. Selectivity of serum immunoreactive prolyl 4-hydroxylase as a marker for hepatic necrosis.
    Nagai Y; Kato M; Toda G
    J Gastroenterol Hepatol; 1992; 7(3):253-6. PubMed ID: 1319223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymes of collagen synthesis and type III procollagen amino-propeptide in serum from Nigerians with hepato-cellular carcinoma and other malignant diseases.
    Bolarin DM; Savolainen ER; Kivirikko KI
    Int J Cancer; 1982 Apr; 29(4):401-5. PubMed ID: 6282764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin.
    Murawaki Y; Kusakabe Y; Hirayama C
    Hepatology; 1991 Dec; 14(6):1167-73. PubMed ID: 1683640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocollagen proline hydroxylase in sera of Ugandans with hepatocellular carcinoma.
    Keiser HR; Vogel CL; Sadikali F
    J Natl Cancer Inst; 1972 Nov; 49(5):1251-5. PubMed ID: 4119495
    [No Abstract]   [Full Text] [Related]  

  • 6. Liver immunoreactive prolyl hydroxylase protein in human primary hepatocellular carcinoma.
    Bolarin D; Andy JJ; Alabi ZO
    Hepatogastroenterology; 1983 Dec; 30(6):230-2. PubMed ID: 6327476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of prolyl hydroxylase analysis in clinical tests].
    Yamada S; Kawasaki H
    Nihon Rinsho; 1989 Dec; 48 Suppl():321-3. PubMed ID: 2560079
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical significance of serum prolyl hydroxylase beta-subunit levels determined using monoclonal antibody].
    Yasuhara M; Matsuda Y; Takada A
    Nihon Shokakibyo Gakkai Zasshi; 1987 Jun; 84(6):1225-32. PubMed ID: 2822982
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunoreactive prolyl hydroxylase protein and galactosylhydroxylysyl glucosyltransferase activity in breast tissues and sera of patients with primary breast cancer.
    Bolarin DM
    Res Commun Chem Pathol Pharmacol; 1983 Mar; 39(3):493-502. PubMed ID: 6304825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate dehydrogenase activity related to histopathological grade of hepatocellular carcinoma in man.
    Glazer RI; Vogel CL; Patel IR; Anthony PP
    Cancer Res; 1974 Nov; 34(11):2975-8. PubMed ID: 4370643
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical significance of serum 7S collagen in various liver diseases.
    Yamada S; Suou T; Kawasaki H; Yoshikawa N
    Clin Biochem; 1992 Dec; 25(6):467-70. PubMed ID: 1335851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum alpha-fetoprotein in 184 Ugandan patients with hepatocellular carcinoma. Clinical, laboratory, and histopathologic correlations.
    Vogel CL; Primack A; McIntire KR; Carbone PP; Anthony PP
    Cancer; 1974 Apr; 33(4):959-64. PubMed ID: 4362109
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum immunoreactive prolyl 4-hydroxylase as a specific marker of hepatocellular necrosis.
    Nagai Y; Toda G
    Clin Chim Acta; 1990 Sep; 190(1-2):109-10. PubMed ID: 2170064
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression pattern of matrix metalloproteinases in human liver.
    Lichtinghagen R; Helmbrecht T; Arndt B; Böker KH
    Eur J Clin Chem Clin Biochem; 1995 Feb; 33(2):65-71. PubMed ID: 7632822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum markers for fibrosis and plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma in comparison with patients with liver cirrhosis.
    Murawaki Y; Ikuta Y; Nishimura Y; Koda M; Kawasaki H
    J Gastroenterol Hepatol; 1996 May; 11(5):443-50. PubMed ID: 8743916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Type III procollagen N-terminal peptide (P-III-P, prolyl hydroxylase (PH), and laminin P1 levels in serum and BALF of radiotherapy patients].
    Matsumoto S; Shindo J; Horiba M; Hara M; Inoue K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jan; 30(1):28-34. PubMed ID: 1320708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectopic production of human chorionic gonadotropin in Ugandan patients with hepatocellular carcinoma.
    Braunstein GD; Vogel CL; Vaitukaitis JL; Ross GT
    Cancer; 1973 Jul; 32(1):223-6. PubMed ID: 4352018
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum prolyl hydroxylase protein in experimental liver cancer.
    Bolarin DM
    Acta Physiol Hung; 1988; 71(1):55-9. PubMed ID: 2839006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Peptidyl prolyl hydroxylase activity in relation to the actual collagen biosynthesis in cotton pellet granuloma of guinea pig (author's transl)].
    Langness U; Nissen R
    Res Exp Med (Berl); 1977 Jul; 170(3):295-302. PubMed ID: 197577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Enzymes of anabolic and catabolic nucleic acid pathways in human hepatomas, in liver of healthy persons, and in liver of patients with cancer of gastrointestinal tract].
    Borzenko BG; Vornovitskaia GI; Belousov IM; Gets G; Drel' KA; Shapot VS
    Biokhimiia; 1977 Jul; 42(7):1266-70. PubMed ID: 198026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.